益丰药房：益丰药房2024年年度报告

ImportantNotes I.TheBoardofDirectors,BoardofSupervisors,directors,supervisorsandseniormanagementoftheCompanyherebyguaranteethatthecontentsareauthentic,accurate,andcomplete,withoutfalserecords,misleadingrepresentationsormaterialomissionsintheAnnualReport,andshalltakeallthejointandseverallegalliabilities. II.AllthedirectorshaveattendedthemeetingoftheBoardofDirectors. III.Pan-ChinaCertifiedPublicAccountants hasissueda standardunqualified auditreportfortheCompany. IV.GaoYi,theCompany’sresponsibleperson,WangYonghui,responsiblepersoninchargeofaccountingwork,and GuanChangfu,theaccountingfirm’sresponsibleperson(accountingsuperintendent)herebydeclareandwarrantthatthefinancialreportintheAnnualReportisauthentic,accurate,andcomplete. V.TheplanofprofitdistributionortheconversionofcapitalreservesintosharecapitalfortheReportingPeriodhasbeenapprovedbytheBoardofDirectors Basedon the audit conducted by Pan-China Certified Public Accountants(special generalpartnership),asofDecember31,2024,theundistributedprofitsintheparentcompany’sfinancialstatementsamountedtoCN¥854,914,834.22. In2024,theCompanyachievedanetprofitattributabletotheparentcompanyamountingtoCN¥1,528,576,669.36.Afteraddingtheundistributedprofitfromthebeginningof2024,whichwasCN¥4,774,244,419.42,anddeductingthestatutorysurplusreserveofCN¥127,737,417.19extractedattheendoftheyear,alongwithadividendpayoutofCN¥505,289,898.50for2023,andadividendpayoutof303,114,161.25formid2024,theprofitavailablefordistributiontoshareholderstotaledCN¥5,366,679,611.84. TheCompanyproposestodistributeacashdividendofCN¥0.40(taxincluded)persharetoallshareholders.AsofMarch31,2025,theCompany’stotalsharecapitalstoodat1,212,416,794shares,resultinginaproposedtotalcashdividenddistributionofCN¥484,966,717.60(taxincluded).ShouldtheCompany’stotalsharecapitalchangebetweenthedisclosuredateofthisprofitdistributionplanandtheequityregistrationdateforitsimplementation,duetofactorssuchasconvertiblebondconversionorrepurchaseandcancellationofsharesgrantedunderequityincentives,theCompanyintendstomaintaintheper-sharedistributionratiowhileadjustingthetotaldistributionamountaccordingly.Anysubsequentchangesintotalsharecapitalwillbeannouncedseparatelywithspecificadjustmentdetails.TheprofitdistributionplanaboveissubjecttoapprovalbytheCompany’sshareholdersatthegeneralmeeting beforeimplementation. VI.Riskstatementonforward-lookingstatements "√Applicable""□Notapplicable" Theforward-lookingstatementssuchasfutureplansanddevelopmentstrategiesintheAnnualReportdonotconstitutea substantivecommitmentoftheCompanytoinvestors.Investorsshouldthereforemakerationalinvestmentbasedonanawarenessofriskfactors. VII.Aretherecasesofnon-operationalfundoccupancybythecontrollingshareholderandotherrelatedparties No VIII.Havetherebeenanybreachesofestablisheddecision-makingproceduresinprovidingguaranteestoexternalpartiesNo IX.HastherebeenasituationwheremorethanhalfofthedirectorscannotguaranteethattheAnnualReportdisclosedbytheCompanyisauthentic,accurate,andcompleteNo X.Significantriskwarnings DuringtheReportingPeriod,nosignificantriskshadasubstantialimpactontheCompany’sproductionandoperationactivities.TheCompanyhasextensivelyelaboratedonpotentialrisksinthisreport.Formoredetails,pleaserefertoSubsection"PotentialRisks"underSectionIII“ManagementDiscussionandAnalysis”. XI.Others "□Applicable""√Notapplicable" Contents SectionI.Paraphrase.............................................................................................................................5SectionII.CompanyProfileandMainFinancialIndicators.................................................................6SectionIII.ManagementDiscussionandAnalysis...............................................................................11SectionIV.CorporateGovernance........................................................................................................45SectionV.EnvironmentalandSocialResponsibility..........................................................................72SectionVI.Importantmatters................................................................................................................74SectionVII.ChangesinSharesandShareholders................................................................................115SectionVIII.OverviewofPreferredShare............................................................................................124SectionIX.OverviewofBonds...........................................................................................................125SectionX.FinancialStatements.........................................................................................................128 SectionI.Paraphrase I.Paraphrase SectionII.CompanyProfileandMainFinancialIndicators I.Companyinformation II.Contactsandcontactinformation III.Basicinformation IV.Informationdisclosureandplaceofthereport V.Companystock VI.Otherrelatedinformation VII.Mainaccountingdataandfinancialindicatorsinrecentthreeyears (i)Mainaccountingda